Varex delivered Q1 FY2026 revenue of 209600000 dollars, up 5% year over year, with operating income of 15400000 dollars and net income attributable to Varex of 2300000 dollars, reflecting improved operating leverage and growth in Industrial revenue.

Varex Imaging delivered solid Q4 results, with $229M in revenue and improved profitability. Medical and Industrial segment sales contributed to an 11% YoY revenue increase. Operating margin improved, and the company generated positive cash flow from operations.

Varex Imaging Corporation reported strong demand in Q2 FY25, leading to year-over-year sales growth in both segments. The company achieved margin expansion, profitability, and cash generation, with revenues reaching $213 million and non-GAAP EPS increasing to $0.26.

Varex Imaging Corporation reported a net loss of $0.1 million for the three months ended January 3, 2025, an improvement from a $0.4 million net loss in the prior quarter. Revenues increased to $199.8 million, up from $190.0 million in the previous quarter, driven by strong performance in both Medical and Industrial segments.

Varex Imaging Corporation reported a decrease in revenue and earnings per share (EPS) for the fourth quarter of fiscal year 2024. Revenue was $206 million, and GAAP net loss per diluted share was $(1.22). The company's cash flow from operations was $26 million, and it ended the year with $213 million in cash and marketable securities.

Varex Imaging Corporation reported revenue of $209 million for Q3 2024, a 10% decrease year-over-year. GAAP EPS was $0.03, and non-GAAP EPS was $0.14. The industrial segment saw a 6% increase driven by cargo inspection, while the medical segment declined by 15%.

Varex Imaging Corporation reported revenue of $206 million, which was in line with guidance but down 10% year-over-year, primarily due to lower sales in China. GAAP net earnings were $0.03 per diluted share, while non-GAAP net earnings were $0.16 per diluted share.

Varex Imaging Corporation reported revenue of $190 million, which was at the midpoint of their guidance. Unfavorable mix in both the Medical and Industrial segments impacted profitability. Revenue was down 8% year-over-year.

Varex Imaging Corporation announced its Q4 FY23 financial results with revenues of $227 million. The company's performance was driven by a strong Industrial segment, which offset lower revenue in the Medical segment, particularly in China. Cash flow from operations was $47 million, and the company finished the fiscal year with $195 million in cash and marketable securities.

Varex Imaging reported revenues of $232 million, a new quarterly record, with a GAAP gross margin of 33% and a non-GAAP gross margin of 34%. The company's cash position increased by $30 million due to efforts to reduce inventory levels and improved profitability.

Varex Imaging Corporation reported revenue of $228 million, up 11% sequentially and 6% year-over-year. GAAP net earnings were $0.10 per diluted share, while non-GAAP net earnings were $0.26 per diluted share.

Varex Imaging's revenue was $206 million, up 3% year-over-year. GAAP net earnings were $0.08 per diluted share and non-GAAP net earnings were $0.21 per diluted share. The company is beginning to see some cautiousness from customers due to the uncertain economic environment.

Varex Imaging Corporation announced strong Q4 FY22 results with record revenues of $231 million, driven by solid global demand and improved supply chain. The company reported GAAP EPS of $0.32 and non-GAAP EPS of $0.42.

Varex Imaging Corporation's revenues were $214 million, flat sequentially, with the Medical segment down 2% and the Industrial segment up 7% from the second quarter of fiscal year 2022. Compared to the third quarter of fiscal year 2021, total revenues increased 2%, with the Medical segment flat and the Industrial segment up 8%. Non-GAAP gross margin increased to 35% in the quarter compared to 34% last quarter and non-GAAP EPS was flat sequentially at $0.37.

Varex Imaging Corporation reported revenues of $215 million for the second quarter of fiscal year 2022. The company's GAAP net earnings were $0.18 per diluted share, while non-GAAP net earnings were $0.37 per diluted share. Revenues increased 8% sequentially, with the Medical segment up 10% and the Industrial segment increasing 3% from the first quarter of fiscal year 2022.

Varex Imaging Corporation reported a quarterly revenue of $199 million, which was below expectations due to supply chain constraints. Non-GAAP EPS was $0.25, and the cash balance reached $158 million at quarter end.

Varex Imaging Corporation reported record quarterly revenue of $226 million in the fourth quarter of fiscal 2021, driven by broad-based strength globally, especially in the Medical Segment. Profitability improved due to strong growth and stable operating expenses, leading to robust cash generation with $51 million in cash flow from operations.

Varex Imaging Corporation announced its Q3 fiscal year 2021 results with revenues of $211 million, a 23% increase year-over-year, driven by demand in both the Medical and Industrial segments. GAAP net earnings were $0.29 per diluted share and non-GAAP net earnings were $0.40 per diluted share. Cash and cash equivalents improved $17 million sequentially to $128 million.

Varex Imaging Corporation's financial results for Q2 2021 exceeded expectations, surpassing pre-COVID revenue levels, driven by strong global CT tube sales and higher sales of industrial digital detectors. Revenues increased 3% year-over-year, and the company benefited from strong expense management.

Varex Imaging Corporation announced its financial results for the first quarter of fiscal year 2021, with revenues of $177 million. The company's performance exceeded expectations, with a sequential revenue increase of 4% over the previous quarter and a significant improvement in non-GAAP gross margin to 34%.

Varex Imaging Corporation announced its Q4 and FY2020 financial results, with Q4 revenues of $170 million. The company's GAAP net loss was $0.66 per diluted share. The impact of COVID-19 on the business has started to stabilize.

Varex Imaging Corporation reported a 13% decline in revenues compared to the previous year's quarter, primarily due to the impact of COVID-19. The company's GAAP net loss was ($0.73) per diluted share. Actions have been taken to reduce annual operating costs by more than $25 million.

Varex Imaging Corporation reported Q2 2020 revenues of $197 million, a slight increase from the prior year. The company experienced a shift in mix between business segments, impacting overall margins. Net loss was ($0.05) per diluted share, while adjusted net earnings were $0.12 per diluted share.

Varex Imaging Corporation announced an 8% increase in revenues for the first quarter of fiscal year 2020, reaching $200 million compared to $186 million in the prior year quarter. The growth was driven by strong sales in CT tubes and products for oncology, dental, and airport baggage screening applications.